Kenny Omega Explains Why He Won't Return to AEW
Former AEW Champion and professional wrestling icon Kenny Omega has explained why he won't return to All Elite Wrestling and will remain with New Japan.
Science Daily2d
Clinical trial shows positive results for potential treatment to combat a challenging rare disease
Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).
GlobalData on MSN2d
FDA approves Azurity Pharmaceuticals’ Danziten for CML treatment
The US Food and Drug Administration (FDA) has approved Azurity Pharmaceuticals’ Danziten (nilotinib), the first and only ...
Get chronic UTIs? Future treatments may add more bacteria to your bladder to beat back harmful microbes
Current methods to deliver bacteria to the bladder are invasive and require repeated catheter insertion. Even when bacteria are successfully released into the bladder, urine will flush out these ...